ArticleFrontiers in immunology2026
Bioinformatics-driven single-cell sequencing analysis of angiogenesis-related genes in rheumatoid arthritis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore angiogenesis-related genes and immune cell profiles in RA and assess their clinical relevance in RA patients. Methods: Gene expression datasets(GEO) of RA synovium were retrieved from the public database, and differential gene and immune infiltration analysis were performed using R. Angiogenesis-related genes were obtained from the Gene Set Enrichment Analysis(GSEA) database, and Receiver Operating Characteristic(ROC) curves were used to identify diagnostic genes based on their expression in RA synovium. Gene Ontology (GO) functional and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted using the DAVID and Metaspace database. Single-cell sequencing data related to RA were analyzed for dimensionality reduction and cell type annotation, with core genes identified. Finally, PBMCs from RA clinical samples were collected for Quantitative Real-Time PCR (RT-qPCR) and clinical correlation analysis. Results: This study identified 11 core genes associated with synovium and angiogenesis in RA. Notably, the diagnostic accuracy rates of IL10, E2F7, and E2F8 were found to be relatively high. Furthermore, we observed that these genes were significantly enriched in key signaling pathways such as HIF1 and VEGFA. Consequently, we determined that HIF1, VEGFA, E2F7, E2F8, and IL-10 are critical factors contributing to RA-related angiogenesis, with a significant correlation noted for the HIF1 signaling pathway. Additionally, our research indicates that various immune cell types, including B cells, plasma cells, T cells, natural killer (NK) cells, monocytes, macrophages, quiescent dendritic cells, mast cells, and neutrophils-are all implicated in the pathogenesis of RA. Relevant analyses demonstrate a positive correlation between HIF1 and IL10 as well as E2F7 and E2F8. However, the relationship between HIF1/VEGFA and common differential immune cell populations such as memory B cells, plasma cells, and activated memory CD4 Conclusion: The study pinpointed HIF1, VEGFA, E2F7, E2F8, and IL-10 as pivotal angiogenic genes whose expression tightly mirrors clinical disease activity. Notably, HIF1, VEGFA, and E2F8 escalate in parallel with increasing severity, are shaped by the inflammatory synovial milieu, and appear to fuel both angiogenesis and RA progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.